Are there any generic versions of Vorasidenib currently available?

Vorasidenib is a targeted drug used to treat IDH mutated low-grade glioma. It has not yet been officially launched in mainland China, nor has it been included in the national medical insurance directory. This means that domestic hospitals or pharmacies are not yet able to provide the drug. If patients need to use it, they can only obtain it through overseas channels, and should use it with caution under the guidance of a doctor to ensure the safety and standardization of treatment.

Currently in the overseas market, the original drug of Voxanib has been launched and sold by an American pharmaceutical company. The common specification is 40mg*30 tablets. Each box may be sold for more than 30,000 yuan. The specific price will vary due to exchange rate fluctuations, regional differences and different purchasing methods. This high price constitutes a significant financial burden for many patients, especially if long-term use is required.

It is worth noting that generic versions of vorsidenib are already on the market in some overseas regions. For example, the generic version produced by Lucius Pharmaceuticals in Laos has the same specification of 40mg*30 tablets and is priced at more than 7,000 yuan per box, which is much lower than the original drug. This generic drug is basically the same as the original drug in terms of drug ingredients, bioequivalence, etc., and is favored by many patients with limited economic conditions.

In general, although Voxanib has not yet been launched in China, more economical generic versions are available overseas, especially the Laos version, which has obvious advantages in terms of cost performance. If patients need medication, it is recommended that they obtain the medication through formal cross-border medical institutions or legal pharmaceutical service platforms. At the same time, complete medical records and doctor's prescriptions should be provided to ensure the safety of medication and avoid risks caused by purchasing through informal channels.

Reference materials:https://www.drugs.com/